CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 43 enrolled
Drug / intervention
clonidine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00350532
NCT00350532Phase 2Completed
CompareCT.gov

Clonidine-induced Spinal Acetylcholine Release: Normal Volunteers vs. Neuropathic Pain

Wake Forest University Health Sciences·interventional·Posted Jul 10, 2006·Updated Sep 10, 2018

In Brief

A Phase 2 clinical trial evaluating clonidine for Pain. Completed, enrolled 43 participants across 2 sites.

Detailed Summary

The purpose of this study is to compare the amount of acetylcholine release after a single injection of clonidine in normal volunteers and individuals with neuropathic pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
CollaboratorsNational Institute of Neurological Disorders and Stroke (NINDS)

Timeline

Phase 2CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 10, 2006
Enrollment StartSep 1, 2004
Primary CompletionMar 1, 2008
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 20.0 years ago

Interventions

clonidinedrug

Patients will receive intrathecal clonidine (or clonidine injected into cerebrospinal fluid)

clonidinedrug

Patients will receive intrathecal clonidine (or clonidine injected into cerebrospinal fluid)